APO Research
Talk to an analyst

APO RESEARCH · REPORT

Advanced Therapy Medicinal Products

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Advanced Therapy Medicinal Products Market Outlook and Growth Opportunities 2026

2 January 2026199 pages

Choose your research edition.

Industry ResearchAdvanced Therapy Medicinal Products Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Advanced Therapy Medicinal Products Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Advanced Therapy Medicinal Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Advanced Therapy Medicinal Products Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Advanced Therapy Medicinal Products Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Advanced Therapy Medicinal Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Advanced Therapy Medicinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Advanced Therapy Medicinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Advanced Therapy Medicinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Advanced Therapy Medicinal Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Advanced Therapy Medicinal Products market include Novartis, Vericel Corporation, UniQure, Spark Therapeutics, PHARMICELL, MEDIPOST, Kolon TissueGene, JCR Pharmaceuticals and Gilead Lifesciences, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Advanced Therapy Medicinal Products market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Advanced Therapy Medicinal Products and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Advanced Therapy Medicinal Products revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Advanced Therapy Medicinal Products market.

Advanced Therapy Medicinal Products Segment by Company

Novartis

Vericel Corporation

UniQure

Spark Therapeutics

PHARMICELL

MEDIPOST

Kolon TissueGene

JCR Pharmaceuticals

Gilead Lifesciences

Celgene Corporation

Bluebird Bio

Advanced Therapy Medicinal Products Segment by Type

Tissue Engineered Product

Cell Therapy

Gene Therapy

CAR-T Therapy

Advanced Therapy Medicinal Products Segment by Application

Hospital

Clinic

Advanced Therapy Medicinal Products Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Advanced Therapy Medicinal Products status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Advanced Therapy Medicinal Products key companies, revenue, market share, and recent developments.

3. To split the Advanced Therapy Medicinal Products breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Advanced Therapy Medicinal Products market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Advanced Therapy Medicinal Products significant trends, drivers, influence factors in global and regions.

6. To analyze Advanced Therapy Medicinal Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Advanced Therapy Medicinal Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Advanced Therapy Medicinal Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Advanced Therapy Medicinal Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Advanced Therapy Medicinal Products industry.

Chapter 3: Detailed analysis of Advanced Therapy Medicinal Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Advanced Therapy Medicinal Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Advanced Therapy Medicinal Products in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Advanced Therapy Medicinal Products Industry Trends Table 2. Advanced Therapy Medicinal Products Industry Drivers Table 3. Advanced Therapy Medicinal Products Industry Opportunities and Challenges Table 4. Advanced Therapy Medicinal Products Industry Restraints Table 5. Global Advanced Therapy Medicinal Products Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Advanced Therapy Medicinal Products Revenue Share by Company (2021-2026) Table 7. Global Advanced Therapy Medicinal Products Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Advanced Therapy Medicinal Products Key Company Manufacturing Base & Headquarters Table 9. Global Advanced Therapy Medicinal Products Company, Product Type & Application Table 10. Global Advanced Therapy Medicinal Products Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Advanced Therapy Medicinal Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Tissue Engineered Product Table 15. Significant Companies of Cell Therapy Table 16. Significant Companies of Gene Therapy Table 17. Significant Companies of CAR-T Therapy Table 18. Global Advanced Therapy Medicinal Products Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Advanced Therapy Medicinal Products Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Advanced Therapy Medicinal Products Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Advanced Therapy Medicinal Products Sales Value Share by Type (2021-2026) Table 22. Global Advanced Therapy Medicinal Products Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospital Table 24. Significant Companies of Clinic Table 25. Global Advanced Therapy Medicinal Products Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Advanced Therapy Medicinal Products Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Advanced Therapy Medicinal Products Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Advanced Therapy Medicinal Products Sales Value Share by Application (2021-2026) Table 29. Global Advanced Therapy Medicinal Products Sales Value Share by Application (2027-2032) Table 30. Global Advanced Therapy Medicinal Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Advanced Therapy Medicinal Products Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Advanced Therapy Medicinal Products Sales Value Share by Region (2021-2026) Table 33. Global Advanced Therapy Medicinal Products Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Advanced Therapy Medicinal Products Sales Value Share by Region (2027-2032) Table 35. Global Advanced Therapy Medicinal Products Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Advanced Therapy Medicinal Products Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Advanced Therapy Medicinal Products Sales Value Market Share by Country (2021-2026) Table 38. Global Advanced Therapy Medicinal Products Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Advanced Therapy Medicinal Products Sales Value Market Share by Country (2027-2032) Table 40. Novartis Company Information Table 41. Novartis Business Overview Table 42. Novartis Advanced Therapy Medicinal Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Novartis Advanced Therapy Medicinal Products Product Portfolio Table 44. Novartis Recent Development Table 45. Vericel Corporation Company Information Table 46. Vericel Corporation Business Overview Table 47. Vericel Corporation Advanced Therapy Medicinal Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Vericel Corporation Advanced Therapy Medicinal Products Product Portfolio Table 49. Vericel Corporation Recent Development Table 50. UniQure Company Information Table 51. UniQure Business Overview Table 52. UniQure Advanced Therapy Medicinal Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. UniQure Advanced Therapy Medicinal Products Product Portfolio Table 54. UniQure Recent Development Table 55. Spark Therapeutics Company Information Table 56. Spark Therapeutics Business Overview Table 57. Spark Therapeutics Advanced Therapy Medicinal Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Spark Therapeutics Advanced Therapy Medicinal Products Product Portfolio Table 59. Spark Therapeutics Recent Development Table 60. PHARMICELL Company Information Table 61. PHARMICELL Business Overview Table 62. PHARMICELL Advanced Therapy Medicinal Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. PHARMICELL Advanced Therapy Medicinal Products Product Portfolio Table 64. PHARMICELL Recent Development Table 65. MEDIPOST Company Information Table 66. MEDIPOST Business Overview Table 67. MEDIPOST Advanced Therapy Medicinal Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. MEDIPOST Advanced Therapy Medicinal Products Product Portfolio Table 69. MEDIPOST Recent Development Table 70. Kolon TissueGene Company Information Table 71. Kolon TissueGene Business Overview Table 72. Kolon TissueGene Advanced Therapy Medicinal Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Kolon TissueGene Advanced Therapy Medicinal Products Product Portfolio Table 74. Kolon TissueGene Recent Development Table 75. JCR Pharmaceuticals Company Information Table 76. JCR Pharmaceuticals Business Overview Table 77. JCR Pharmaceuticals Advanced Therapy Medicinal Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. JCR Pharmaceuticals Advanced Therapy Medicinal Products Product Portfolio Table 79. JCR Pharmaceuticals Recent Development Table 80. Gilead Lifesciences Company Information Table 81. Gilead Lifesciences Business Overview Table 82. Gilead Lifesciences Advanced Therapy Medicinal Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Gilead Lifesciences Advanced Therapy Medicinal Products Product Portfolio Table 84. Gilead Lifesciences Recent Development Table 85. Celgene Corporation Company Information Table 86. Celgene Corporation Business Overview Table 87. Celgene Corporation Advanced Therapy Medicinal Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Celgene Corporation Advanced Therapy Medicinal Products Product Portfolio Table 89. Celgene Corporation Recent Development Table 90. Bluebird Bio Company Information Table 91. Bluebird Bio Business Overview Table 92. Bluebird Bio Advanced Therapy Medicinal Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Bluebird Bio Advanced Therapy Medicinal Products Product Portfolio Table 94. Bluebird Bio Recent Development Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Advanced Therapy Medicinal Products Product Image Figure 2. Global Advanced Therapy Medicinal Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Advanced Therapy Medicinal Products Market Size (2021-2032) & (US$ Million) Figure 4. Global Advanced Therapy Medicinal Products Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Tissue Engineered Product Image Figure 8. Cell Therapy Image Figure 9. Gene Therapy Image Figure 10. CAR-T Therapy Image Figure 11. Global Advanced Therapy Medicinal Products Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Advanced Therapy Medicinal Products Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Advanced Therapy Medicinal Products Sales Value Share by Type (2021-2032) Figure 14. Hospital Image Figure 15. Clinic Image Figure 16. Global Advanced Therapy Medicinal Products Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Advanced Therapy Medicinal Products Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Advanced Therapy Medicinal Products Sales Value Share by Application (2021-2032) Figure 19. Global Advanced Therapy Medicinal Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Advanced Therapy Medicinal Products Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Advanced Therapy Medicinal Products Sales Value (2021-2032) & (US$ Million) Figure 22. North America Advanced Therapy Medicinal Products Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Advanced Therapy Medicinal Products Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Advanced Therapy Medicinal Products Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Advanced Therapy Medicinal Products Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Advanced Therapy Medicinal Products Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Advanced Therapy Medicinal Products Sales Value (2021-2032) & (US$ Million) Figure 28. South America Advanced Therapy Medicinal Products Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Advanced Therapy Medicinal Products Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Advanced Therapy Medicinal Products Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Tissue Engineered Product
  • Cell Therapy
  • Gene Therapy
  • CAR-T Therapy
Applications
  • Hospital
  • Clinic
Companies covered
  • Novartis
  • Vericel Corporation
  • UniQure
  • Spark Therapeutics
  • PHARMICELL
  • MEDIPOST
  • Kolon TissueGene
  • JCR Pharmaceuticals
  • Gilead Lifesciences
  • Celgene Corporation
  • Bluebird Bio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Advanced Therapy Medicinal Products Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Advanced Therapy Medicinal Products Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Advanced Therapy Medicinal Products Market Dynamics
  1. 2.1 Advanced Therapy Medicinal Products Industry Trends
  2. 2.2 Advanced Therapy Medicinal Products Industry Drivers
  3. 2.3 Advanced Therapy Medicinal Products Industry Opportunities and Challenges
  4. 2.4 Advanced Therapy Medicinal Products Industry Restraints
3 Advanced Therapy Medicinal Products Market by Company
  1. 3.1 Global Advanced Therapy Medicinal Products Company Revenue Ranking in 2025
  2. 3.2 Global Advanced Therapy Medicinal Products Revenue by Company (2021-2026)
  3. 3.3 Global Advanced Therapy Medicinal Products Company Ranking (2024-2026)
  4. 3.4 Global Advanced Therapy Medicinal Products Company Manufacturing Base and Headquarters
  5. 3.5 Global Advanced Therapy Medicinal Products Company Product Type and Application
  6. 3.6 Global Advanced Therapy Medicinal Products Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Advanced Therapy Medicinal Products Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Advanced Therapy Medicinal Products Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Advanced Therapy Medicinal Products Market by Type
  1. 4.1 Advanced Therapy Medicinal Products Type Introduction
  2. 4.1.1 Tissue Engineered Product
  3. 4.1.2 Cell Therapy
  4. 4.1.3 Gene Therapy
  5. 4.1.4 CAR-T Therapy
  6. 4.2 Global Advanced Therapy Medicinal Products Sales Value by Type
  7. 4.2.1 Global Advanced Therapy Medicinal Products Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Advanced Therapy Medicinal Products Sales Value by Type (2021-2032)
  9. 4.2.3 Global Advanced Therapy Medicinal Products Sales Value Share by Type (2021-2032)
5 Advanced Therapy Medicinal Products Market by Application
  1. 5.1 Advanced Therapy Medicinal Products Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Advanced Therapy Medicinal Products Sales Value by Application
  5. 5.2.1 Global Advanced Therapy Medicinal Products Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Advanced Therapy Medicinal Products Sales Value by Application (2021-2032)
  7. 5.2.3 Global Advanced Therapy Medicinal Products Sales Value Share by Application (2021-2032)
6 Advanced Therapy Medicinal Products Regional Value Analysis
  1. 6.1 Global Advanced Therapy Medicinal Products Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Advanced Therapy Medicinal Products Sales Value by Region (2021-2032)
  3. 6.2.1 Global Advanced Therapy Medicinal Products Sales Value by Region: 2021-2026
  4. 6.2.2 Global Advanced Therapy Medicinal Products Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Advanced Therapy Medicinal Products Sales Value (2021-2032)
  7. 6.3.2 North America Advanced Therapy Medicinal Products Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Advanced Therapy Medicinal Products Sales Value (2021-2032)
  10. 6.4.2 Europe Advanced Therapy Medicinal Products Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Advanced Therapy Medicinal Products Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Advanced Therapy Medicinal Products Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Advanced Therapy Medicinal Products Sales Value (2021-2032)
  16. 6.6.2 South America Advanced Therapy Medicinal Products Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Advanced Therapy Medicinal Products Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Advanced Therapy Medicinal Products Sales Value Share by Country, 2025 VS 2032
7 Advanced Therapy Medicinal Products Country-level Value Analysis
  1. 7.1 Global Advanced Therapy Medicinal Products Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Advanced Therapy Medicinal Products Sales Value by Country (2021-2032)
  3. 7.2.1 Global Advanced Therapy Medicinal Products Sales Value by Country (2021-2026)
  4. 7.2.2 Global Advanced Therapy Medicinal Products Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Advanced Therapy Medicinal Products Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Advanced Therapy Medicinal Products Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Advanced Therapy Medicinal Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Advanced Therapy Medicinal Products Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Vericel Corporation
  8. 8.2.1 Vericel Corporation Company Information
  9. 8.2.2 Vericel Corporation Business Overview
  10. 8.2.3 Vericel Corporation Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Vericel Corporation Advanced Therapy Medicinal Products Product Portfolio
  12. 8.2.5 Vericel Corporation Recent Developments
  13. 8.3 UniQure
  14. 8.3.1 UniQure Company Information
  15. 8.3.2 UniQure Business Overview
  16. 8.3.3 UniQure Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  17. 8.3.4 UniQure Advanced Therapy Medicinal Products Product Portfolio
  18. 8.3.5 UniQure Recent Developments
  19. 8.4 Spark Therapeutics
  20. 8.4.1 Spark Therapeutics Company Information
  21. 8.4.2 Spark Therapeutics Business Overview
  22. 8.4.3 Spark Therapeutics Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Spark Therapeutics Advanced Therapy Medicinal Products Product Portfolio
  24. 8.4.5 Spark Therapeutics Recent Developments
  25. 8.5 PHARMICELL
  26. 8.5.1 PHARMICELL Company Information
  27. 8.5.2 PHARMICELL Business Overview
  28. 8.5.3 PHARMICELL Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  29. 8.5.4 PHARMICELL Advanced Therapy Medicinal Products Product Portfolio
  30. 8.5.5 PHARMICELL Recent Developments
  31. 8.6 MEDIPOST
  32. 8.6.1 MEDIPOST Company Information
  33. 8.6.2 MEDIPOST Business Overview
  34. 8.6.3 MEDIPOST Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  35. 8.6.4 MEDIPOST Advanced Therapy Medicinal Products Product Portfolio
  36. 8.6.5 MEDIPOST Recent Developments
  37. 8.7 Kolon TissueGene
  38. 8.7.1 Kolon TissueGene Company Information
  39. 8.7.2 Kolon TissueGene Business Overview
  40. 8.7.3 Kolon TissueGene Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kolon TissueGene Advanced Therapy Medicinal Products Product Portfolio
  42. 8.7.5 Kolon TissueGene Recent Developments
  43. 8.8 JCR Pharmaceuticals
  44. 8.8.1 JCR Pharmaceuticals Company Information
  45. 8.8.2 JCR Pharmaceuticals Business Overview
  46. 8.8.3 JCR Pharmaceuticals Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  47. 8.8.4 JCR Pharmaceuticals Advanced Therapy Medicinal Products Product Portfolio
  48. 8.8.5 JCR Pharmaceuticals Recent Developments
  49. 8.9 Gilead Lifesciences
  50. 8.9.1 Gilead Lifesciences Company Information
  51. 8.9.2 Gilead Lifesciences Business Overview
  52. 8.9.3 Gilead Lifesciences Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Gilead Lifesciences Advanced Therapy Medicinal Products Product Portfolio
  54. 8.9.5 Gilead Lifesciences Recent Developments
  55. 8.10 Celgene Corporation
  56. 8.10.1 Celgene Corporation Company Information
  57. 8.10.2 Celgene Corporation Business Overview
  58. 8.10.3 Celgene Corporation Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Celgene Corporation Advanced Therapy Medicinal Products Product Portfolio
  60. 8.10.5 Celgene Corporation Recent Developments
  61. 8.11 Bluebird Bio
  62. 8.11.1 Bluebird Bio Company Information
  63. 8.11.2 Bluebird Bio Business Overview
  64. 8.11.3 Bluebird Bio Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bluebird Bio Advanced Therapy Medicinal Products Product Portfolio
  66. 8.11.5 Bluebird Bio Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst